Emanuele Sasso

9PUBLICATIONS
17CO-AUTHORS
Cancer geneticsMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 05, 2024
Integrating system biology and intratumor gene therapy by trans-complementing the appropriate co-stimulatory molecule as payload in oncolytic herpes virus.

A Finizio, P Pagano, A Napolano

|Jun 28, 2023
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays.

Margherita Passariello, Speranza Esposito, Lorenzo Manna

|Feb 25, 2023
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies.

Lorella Tripodi, Emanuele Sasso, Sara Feola

|Nov 11, 2022
New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC.

Rosa Rapuano Lembo, Lorenzo Manna, Guendalina Froechlich

|May 28, 2022
A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab.

Margherita Passariello, Veronica Ferrucci, Emanuele Sasso

|Mar 10, 2022
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand.

Nicola Zambrano, Guendalina Froechlich, Dejan Lazarevic

Pageof 2

Frequent Collaborators

6 joint publications

Claudia De Lorenzo

4 joint publications

Nicola Zambrano

1 joint publications

Alfredo Nicosia

1 joint publications

Anna Morena D'Alise